Affordable Access

A novel Gcn5p inhibitor represses cell growth, gene transcription and histone acetylation in budding yeast.

Authors
  • Ornaghi, Prisca
  • Rotili, Dante
  • Sbardella, Gianluca
  • Mai, Antonello
  • Filetici, Patrizia
Type
Published Article
Journal
Biochemical Pharmacology
Publisher
Elsevier
Publication Date
Sep 15, 2005
Volume
70
Issue
6
Pages
911–917
Identifiers
PMID: 16043126
Source
Medline
License
Unknown

Abstract

Histone acetyltransferases are key chromatin regulators responsible for transcriptional activation and cell cycle progression. We propose a simple yeast-based assay to determine the specificity and targets of novel Gcn5p inhibitors. Here, we report the finding of a novel, small molecule, MC1626, which is able to inhibit yeast cell growth, Gcn5p-dependent gene transcription and acetylation of the histone H3 N-terminal tail in vivo. Because HATs misregulation is invariably associated with human diseases, the identification of MC1626 as a novel cell-permeable Gcn5p inhibitor suggests that it may be a very useful starting tool for the further development of new molecules to be applied to expression profiling of genes regulated by histone H3 acetylation. In addition, our results demonstrate that MC1626 is a Gcn5p-dependent yeast growth inhibitor.

Report this publication

Statistics

Seen <100 times